Core Viewpoint - Charming Medical Limited, a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies, has successfully completed its initial public offering (IPO) and has raised approximately $7.36 million in gross proceeds from the offering, including an over-allotment option exercised by underwriters [1][2]. Company Overview - Charming Medical Limited integrates TCM principles with modern technology to enhance quality of life and promote holistic well-being. The company operates four wellness centers in Hong Kong, offering services such as womb-warming therapy, pelvic detox therapy, moxibustion, prenatal massage, and traditional abdominal binding, focusing on women's health issues [6]. - Under the "Beauty Lab" brand, the company develops and distributes TCM-inspired supplements and beauty products aimed at improving women's constitution and vitality. These products include uterine care patches, probiotic washes, and nourishing herbal formulations [6]. - The company also provides technical training, dietary therapy consultancy, and franchise opportunities to extend its wellness philosophy to other practitioners and entrepreneurs [6]. Offering Details - The IPO consisted of 1,600,000 Class A ordinary shares priced at $4.00 per share, with an additional 240,000 shares purchased through the over-allotment option, resulting in gross proceeds of $0.96 million from the over-allotment [1][2]. - The offering was conducted on a firm commitment basis, with Cathay Securities, Inc. acting as the representative of the underwriters [3]. - The registration statement for the offering was filed with the SEC and declared effective on September 30, 2025, with a final prospectus available on the SEC's website [4].

Core Viewpoint - Grande Group Limited has successfully completed the over-allotment option of its initial public offering, raising additional funds to support its corporate finance advisory and asset management services [1][2]. Group 1: Offering Details - The over-allotment option allowed the underwriter to purchase an additional 281,250 Class A ordinary shares at a price of US$5.00 per share, resulting in gross proceeds of US$1,406,250 [1][2]. - The total gross proceeds from the initial public offering increased to approximately US$10.78 million before deducting underwriting discounts and other expenses [2]. Group 2: Use of Proceeds - The company plans to utilize the net proceeds from the offering to strengthen its corporate finance advisory business, develop its asset management business, establish equity capital market services, and for general working capital purposes [3]. Group 3: Company Background - Grande Group Limited, through its subsidiary Grande Capital Limited, is a Hong Kong-based financial services provider focused on corporate finance advisory and IPO sponsor services [7]. - Grande Capital Limited is licensed by the Securities and Futures Commission of Hong Kong to engage in regulated activities related to dealing in securities and advising on corporate finance [7].